{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Ceftriaxone Sodium is a generic antibiotic used to treat bacterial infections. It's administered as an injection (intramuscular or intravenous) in strengths of 250mg, 500mg, 1g, or 2g per vial. Manufactured by Qilu Pharmaceutical Co., Ltd. and Apotex Corp., it's available as a prescription drug. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Ceftriaxone sodium \u2014 ANDA 065204 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065204", "mediaType": "text/html", "title": "Ceftriaxone sodium"}], "identifier": "ANDA065204", "issued": "2016-09-16", "keyword": ["drug", "fda", "health-care", "pharmaceuticals", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Ceftriaxone sodium"}